Bausch + Lomb Corporation (BLCO)

NYSE: BLCO · IEX Real-Time Price · USD
16.51
-0.72 (-4.18%)
May 18, 2022 4:00 PM EDT - Market closed
Market Cap5.78B
Revenue (ttm)3.71B
Net Income (ttm)-69.00M
Shares Out350.00M
EPS (ttm)-0.20
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume488,154
Open17.08
Previous Close17.23
Day's Range16.30 - 17.23
52-Week Range16.01 - 19.18
Betan/a
Analystsn/a
Price Targetn/a
Earnings Daten/a

About BLCO

Bausch + Lomb is a leading global eye health company dedicated to protecting and enhancing the gift of sight for millions of people around the world—from the moment of birth through every phase of life. Our comprehensive portfolio of over 400 products is fully integrated and built to serve our customers across the full spectrum of their eye health needs throughout their lives. Our iconic brand is built on the deep trust and loyalty of our customers established over our nearly 170-year history. We have a significant global research, developmen...

IndustryHealth Care Equipment & Supplies
IPO DateMay 6, 2022
CEOJoseph C. Papa
Employees12,500
Stock ExchangeNYSE
Ticker SymbolBLCO
Full Company Profile

Financial Performance

Financial Statements

News

Bausch + Lomb Corporation Files Financial Statements for the First Quarter of 2022

VAUGHAN, ON , May 16, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "Company"), a leading global eye health company dedicated to helping people see better to li...

2 days ago - PRNewsWire

Bausch + Lomb Announces Participation at the RBC Capital Markets Global Healthcare Conference

VAUGHAN, ON , May 13, 2022 /PRNewswire/ -- Bausch + Lomb Corporation, (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, today...

5 days ago - PRNewsWire

New Survey Shows Retina Specialists Believe Suprachoroidal Administration is an Option for Patients With Macular Edem...

Survey Reinforces Need for Innovative Therapies, Including Options Administered Through Suprachoroidal Space VAUGHAN, ON , May 12, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausc...

6 days ago - PRNewsWire

Bausch Health And Bausch + Lomb Corporation Announce Closing Of Initial Public Offering Of Bausch + Lomb And Related ...

LAVAL, QC and VAUGHAN, ON , May 10, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb") and Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health") today announced t...

Other symbols:BHC
1 week ago - PRNewsWire

BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today

Here's what investors in Bausch + Lomb may want to know about the highly anticipated BLCO stock IPO, which took place today. The post BLCO Stock: 7 Things to Know About the Bausch + Lomb IPO Today appea...

1 week ago - InvestorPlace

Bausch + Lomb valued at $6.5 billion after stock ticks up in NYSE debut

(Reuters) -Bausch + Lomb was valued at $6.48 billion in its U.S. market debut on Friday as the eye-care company's shares opened nearly 3% above an offer price that was well below the targeted range.

1 week ago - Reuters

BAUSCH + LOMB CORPORATION LAUNCHES AS A PUBLICLY TRADED COMPANY

Bausch + Lomb Begins Trading under "BLCO" on NYSE and TSX Fully Integrated Eye Health Business Sets Its Sights On Helping the World See Better To Live Better VAUGHAN, ON , May 6, 2022 /PRNewswire/ -- Ba...

1 week ago - PRNewsWire

Bausch + Lomb stock opens with a slight gain, to value the company at about $6.5 billion

Bausch + Lomb Corp.'s stock BLCO, +5.39% debuted Friday with a slight gain, which helped justify the disappointing pricing overnight of the lenses and medical devices maker's initial public offering. Th...

1 week ago - Market Watch

Busted Bausch + Lomb IPO To Doom IPO Market, Cash Burning Startups

Bausch + Lomb's busted IPO will cost its parent billions in write-downs. It also signals trouble ahead for the IPO market and venture backed startups

1 week ago - Forbes

Bausch + Lomb prices IPO at $18 a share, below expectations

Bausch + Lomb Corp. priced its IPO at $18 a share Thursday, falling short of expectations as it became the first big company in months to try going public into a turbulent stock market.

1 week ago - Fox Business

Bausch + Lomb Corporation Announces Pricing of IPO

LAVAL, QC and VAUGHAN, ON, May 5, 2022 /PRNewswire/ -- Bausch + Lomb Corporation ("Bausch + Lomb"), a wholly owned subsidiary of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("Bausch Health"), today ann...

1 week ago - PRNewsWire

The Wall Street Journal: Bausch + Lomb prices IPO at $18 a share, below expectations

Bausch + Lomb Corp. BLCO,  priced its IPO at $18 a share Thursday, falling short of expectations as it became the first big company in months to try going public into a turbulent stock market.

1 week ago - Market Watch

Bausch + Lomb's IPO Will Likely be Priced Below Expectations

In a move that highlights the constraints of the current market, eye care company Bausch + Lomb will likely price its initial public offering (IPO) at the low end of expectations, The Wall Street Journa...

1 week ago - PYMNTS

Bausch + Lomb IPO: What You Need to Know

Bausch + Lomb, a well-known leader in eye care, is about to hit Wall Street in what investment bankers almost certainly hope will jump-start a weak initial public offering (IPO) market. Bausch Health Co...

Other symbols:BHC
2 weeks ago - Kiplinger

BLCO Stock IPO: When Does Bausch + Lomb Go Public? What Is the Bausch + Lomb IPO Price Range?

Here's what investors may want to know about the upcoming BLCO stock IPO, as Bausch + Lomb is split off from its parent company this week. The post BLCO Stock IPO: When Does Bausch + Lomb Go Public?

Other symbols:BHC
2 weeks ago - InvestorPlace

IPO Report: U.S. IPO market bracing for second-biggest deal of the year so far in eyecare health company Bausch + Lomb

The U.S. initial public offering market is bracing for what is expected to be the second-biggest deal of the year so far this week, that of eyecare company Bausch & Lomb, which is expected to raise up t...

Other symbols:BHC
2 weeks ago - Market Watch